Literature DB >> 18761415

Strain-specific seroepidemiology and reinfection of cytomegalovirus.

Kei Ishibashi1, Tadahiko Tokumoto, Hiroki Shirakawa, Koichi Hashimoto, Nobuhiro Kushida, Tomohiko Yanagida, Keiichi Shishido, Ken Aikawa, Osamu Yamaguchi, Hiroshi Toma, Kazunari Tanabe, Tatsuo Suzutani.   

Abstract

Although there have been some reports describing the serostatus of cytomegalovirus, strain-specific antibody responses and their distribution remain unknown. In this study, ELISA using fusion proteins encompassing epitope of glycoprotein H from both AD169 and Towne strains was used to test 352 blood donors. Of these 352 donors, 207 were analyzed for strain-specific glycoprotein H antibodies. Of the 44 donors whose serum contained antibodies against both AD169 and Towne, 27 (60%) were aged 50 years or over (p = 0.0003). This may indicate serological evidence of reinfection with cytomegalovirus in the elder population. The nucleotide sequence analysis of cytomegalovirus glycoprotein H from the peripheral blood of the cytomegalovirus-positive renal transplant recipients showed that our strain-specific ELISA can reveal cytomegalovirus reinfection after transplantation.

Mesh:

Substances:

Year:  2008        PMID: 18761415     DOI: 10.1016/j.micinf.2008.08.001

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

1.  A novel real-time PCR method for determination and quantification of each cytomegalovirus glycoprotein H subtype in clinical samples.

Authors:  Kazufumi Ikuta; Ken Ishioka; Yuka Sato; Takashi Imamura; Kimisato Asano; Shin Koyano; Naoki Inoue; Tatsuo Suzutani
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

2.  Mixed infection and strain diversity in congenital cytomegalovirus infection.

Authors:  Shannon A Ross; Zdenek Novak; Sunil Pati; Raj Kumar Patro; Jennifer Blumenthal; Vishwanath R Danthuluri; Amina Ahmed; Marian G Michaels; Pablo J Sánchez; David I Bernstein; Robert W Tolan; April L Palmer; William J Britt; Karen B Fowler; Suresh B Boppana
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

3.  Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time.

Authors:  Irene Görzer; Christian Guelly; Slave Trajanoski; Elisabeth Puchhammer-Stöckl
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

4.  Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection.

Authors:  Matthew L Goodwin; Helen S Webster; Hsuan-Yuan Wang; Jennifer A Jenks; Cody S Nelson; Joshua J Tu; Jesse F Mangold; Sarah Valencia; Justin Pollara; Whitney Edwards; Jason S McLellan; Daniel Wrapp; Tong-Ming Fu; Ningyan Zhang; Daniel C Freed; Dai Wang; Zhiqiang An; Sallie R Permar
Journal:  Virology       Date:  2020-07-22       Impact factor: 3.616

5.  Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial.

Authors:  Takehiko Mori; Yoshinobu Kanda; Katsuto Takenaka; Shinichiro Okamoto; Jun Kato; Junya Kanda; Goichi Yoshimoto; Hisashi Gondo; Sayaka Doi; Masaki Inaba; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2016-10-28       Impact factor: 2.319

6.  The immunity features and defects against primary cytomegalovirus infection post-splenectomy indicate an immunocompromised status: A PRISMA-compliant meta-analysis.

Authors:  George Dimitrios Liatsos
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

7.  Pre-Transplant Screening for Latent Adenovirus in Donors and Recipients.

Authors:  Gabriella Piatti
Journal:  Open Microbiol J       Date:  2016-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.